Veeva Vault for Life Sciences: What It Does and Where It Fits

Veeva Vault Is One Validated Platform Carrying 50+ Applications

The first Vault application you configure sets the pattern for every one after it. Veeva describes the Vault Platform as one system that manages data, content and AI agents together. By Veeva’s own count, it supports 50+ applications in a validated environment across R&D and Commercial.

Vault manages the regulated records life sciences companies must control. On the R&D side, that means clinical trials, regulatory submissions, quality processes and product safety. On the Commercial side, it covers field sales, promotional content and medical engagement.

The practical consequence is reuse. Workflows, security roles and integrations built for one application give the second a familiar starting point. That cuts both ways. A poorly designed first Vault, with messy roles or naming, gets copied into every application after it, so design the first rollout as the data foundation for later modernization.

Every Vault Application Runs on the Same Core Platform

Admin skills learned in one Vault application carry into the next, because Quality, CRM and every other application are built from the same platform tools.

Documents, Binders and Workflows Behave the Same Everywhere

Documents are the base unit in every Vault, and each one carries its own version history. Binders group documents into a structured set, such as an electronic trial master file (eTMF) for a clinical study or a regulatory submission package. Workflows route content and records through review, approval and signature. Dashboards and search let teams check status and find content across the Vault.

When you evaluate a new application, find out how much of it is configuration of these shared tools and how much is new capability. That split tells you how much your existing admins can own without outside help.

Domains and Vaults Decide Who Sees What

Your domain structure is an early architecture decision that is hard to undo. A company can run one or more Vault domains, according to Veeva, and each domain holds one or more Vaults. Users can move between Vaults in the same domain without signing in again. Decide early how you will split Vaults across business units, regions or functions, because that split governs access and reporting later.

Two rules come up constantly. FDA’s 21 CFR Part 11 covers electronic records and electronic signatures in the US. Annex 11 of the EU GMP guidelines covers computerized systems. Validation work often includes installation qualification (IQ) and operational qualification (OQ), which confirm a system is installed correctly and works as specified.

Three misconceptions cause trouble. Buying Vault does not make a company Part 11 compliant. Vault supplies controls and validated releases, while your procedures, configuration, training and record-keeping decide compliance.

Veeva’s validation of its own software doesn’t remove your testing either. You still confirm your configuration behaves as intended, which is what sandbox access before each production upgrade is for.

Validation is also never a one-time project. Multiple releases a year mean impact assessments and test evidence need a refresh every cycle, so put ownership in writing for each Vault application.

Vault Upgrades Arrive on a Fixed Calendar, so Testing Is Routine

Vault applications upgrade on a fixed rhythm, and the teams that cope best treat release testing as standing work. Veeva documents three fully validated major releases a year for Vault CRM, one every four months. Each release reaches customer sandboxes two weeks before the production upgrade.

Release names follow a year-and-number pattern, so 26R2 is the second general release of 2026. Rollouts happen in waves. Veeva staged Vault CDMS 26R2 with pre-release on July 3 and July 10, 2026. Production followed in two waves, on July 31 and August 7, 2026.

A standing release-readiness routine for each Vault application lets your team handle every upgrade with less guesswork.

Veeva AI Agents Are Rolling Out One Application at a Time

Veeva AI Agents reach each Vault application family on its own schedule, so the timing your team faces depends on which applications you run. In October 2025, Veeva published the planned rollout shown below.

The first wave arrived on schedule. Veeva announced on December 3, 2025 that AI agents were available for Vault CRM and PromoMats. For the April and August 2026 waves, ask your Veeva account team which agents you can use in your current release.

Veeva is also building a separate product called Veeva Falcon, which it describes as an agentic labor platform for clinical, regulatory and safety work. In Veeva’s second-quarter fiscal 2027 results, Falcon had five early adopters and was on track for first go-lives in 2026. In the same quarter, Veeva acquired Copli and launched Veeva Falcon MLR, aimed at medical, legal and regulatory review.

Agents that draft, classify or route regulated content still sit inside validated processes. Settle how you will approach validating AI for GxP use before an agent touches a record an inspector might read.

Vault CRM Adoption Is Climbing, but the Biggest Migrations Lie Ahead

Veeva’s public numbers show a large, growing customer base and a CRM migration that is far from finished at the top of the market. Veeva’s fiscal year ends January 31, so fiscal 2027 runs from February 2026 to January 2027. The table separates results from forecasts and live customers from committed ones.

The customer counts cover all Veeva products, not only Vault. The two segments overlap, because some customers buy both. On growth, Veeva reported that fiscal 2026 revenue rose 16% year over year. Its Q2 fiscal 2027 revenue rose 18%.

The Vault CRM figures are the clearest public signal of migration pace. Live customers rose from more than 125 at the end of January 2026 to more than 180 by late August. Yet only five top-20 biopharmas were live, against 12 committed. Most of the largest, most complex migrations are still ahead, and they face the same 2029 cutoff as everyone else. Expect competition for experienced migration resources to tighten as that date approaches.

Signing in to Vault Starts with Your Company’s Domain or VeevaID

Most Vault sign-in and support questions get answered inside your own company first, because your Vault admin controls access. Work through these steps in order.

Quick Answers

What Is Veeva Vault For?

Veeva Vault is for managing the regulated content, data and processes life sciences companies must control. It runs clinical, regulatory, quality, safety, medical and commercial applications on one validated cloud platform.

How Do I Contact Veeva Vault Customer Service?

Start with your company’s Vault administrator, who manages your account and access. For product how-to questions, use the Vault Help site. If you use apps like Study Portal or SiteVault, sign in through VeevaID at id.veeva.com.

When Does Legacy Veeva CRM Support End?

Veeva will support the Salesforce-based Veeva CRM until December 31, 2029. Earlier filings gave September 1, 2030.

Five Questions to Answer Before Your Next Vault Planning Meeting

Five answers will show where Vault fits in your plan for the next budget cycle. Work through them this week with your IT, quality and commercial leads. Choose the order deliberately, and you build with purpose, not patchwork.

Smartbridge can work with you as a strategic partner to turn those answers into a sequenced plan with measurable progress at each release. Talk to a Smartbridge expert about Veeva integration and migration.